<DOC>
	<DOCNO>NCT02987387</DOCNO>
	<brief_summary>This study confirm safety effectiveness Edwards Lifesciences SAPIEN XT Transcatheter Heart Valve ( THV ) System patient dysfunctional right ventricular outflow tract ( RVOT ) conduit clinical indication intervention post-market setting .</brief_summary>
	<brief_title>COMPASSION XT PAS - Post-approval Study SAPIEN XT THV Patients With Pulmonary Valve Dysfunction</brief_title>
	<detailed_description>The study prospective , non-randomized , multi-center clinical study ass safety effectiveness pulmonic implantation SAPIEN THV patient dysfunctional RVOT conduit require treatment moderate severe pulmonary regurgitation ( PR ) transthoracic echocardiography ( TTE ) and/or RVOT conduit obstruction mean gradient â‰¥ 35 mmHg TTE .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Pulmonary Valve Insufficiency</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Pulmonary Valve Stenosis</mesh_term>
	<criteria>1 . Patient dysfunctional , noncompliant RVOT conduit . 2 . The patient/patient 's legally authorize representative inform nature study , agree provision provide write informed consent . 1 . Inability tolerate anticoagulation/antiplatelet regimen 2 . Active bacterial endocarditis</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Tetralogy Fallot</keyword>
	<keyword>Aortic Valve Defect/Disease Resulting Ross Procedure</keyword>
	<keyword>Transcatheter pulmonary valve implantation</keyword>
	<keyword>Transcatheter pulmonary valve replacement</keyword>
	<keyword>Pulmonary Atresia</keyword>
	<keyword>Pulmonary Stenosis</keyword>
</DOC>